AC Immune S.A.
AC Immune S.A. (ACIU) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ACIU · as of Jun 8, 2026
Key Statistics
Explore AC Immune S.A. Data
aciu stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 88.9%
The ACIU analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $7.00, representing +211.11% upside from the current price of $2.25.
Competitors & Peers
aciu competitorsACIU
ALDX
AMRN
ANNX
ANRO
CLLSStock Performance
Full HistoryAbout AC Immune S.A.
AC Immune S.A. AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated w…
what is ac immune s.a. · aciu stock overview · ac immune s.a. company profile · who is ac immune s.a. ceo · aciu NASDAQ · ac immune s.a. headquarters · ac immune s.a. business segments
About Stock Overview & Key Data
AC Immune S.A. (ACIU) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 23, 2016. As of the latest trading session, ACIU stock price is $2.25, with a market capitalization of $229.0M. The stock has returned +7.14% over the past 12 months and -28.34% year-to-date.
According to 9 Wall Street analysts, the consensus rating for AC Immune S.A. stock is Buy, with an average 12-month price target of $7.00. In fiscal year 2025, AC Immune S.A. reported revenue of $3.6M and net income of -$70.4M. For detailed data — including AC Immune S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AC Immune S.A. (ACIU) stock price is $2.25. The stock is traded on NASDAQ under the ticker symbol ACIU. The 52-week range is $1.65 – $4.00.